Medicare To Cover "Routine Care Costs" Of Private And Public Clinical Trials
This article was originally published in The Gray Sheet
Executive SummaryThe Health Care Financing Administration intends to allow Medicare coverage "of routine care costs" for all device trials conducted under IDEs, provided they fall within statutory benefits, according to the agency.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.